Transplant and Immunocompromised Host Infectious Diseases, Infectious Diseases Division, Massachusetts General Hospital, Boston, MA 02114, USA.
Transplantation. 2010 Apr 15;89(7):779-95. doi: 10.1097/TP.0b013e3181cee42f.
Cytomegalovirus (CMV) remains one of the most common infections after solid organ transplantation, resulting in significant morbidity, graft loss, and occasional mortality. Management of CMV varies considerably among transplant centers. A panel of experts on CMV and solid organ transplant was convened by The Infectious Diseases Section of The Transplantation Society to develop evidence and expert opinion-based consensus guidelines on CMV management including diagnostics, immunology, prevention, treatment, drug resistance, and pediatric issues.
巨细胞病毒(CMV)仍然是实体器官移植后最常见的感染之一,导致发病率、移植物丢失和偶尔的死亡率显著增加。CMV 的管理在移植中心之间存在很大差异。由移植学会传染病分会召集的一组 CMV 和实体器官移植专家,制定了基于证据和专家意见的 CMV 管理共识指南,包括诊断、免疫学、预防、治疗、耐药性和儿科问题。